Céline Guigoni - Publications

Affiliations: 
Aix-Marseille 3 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Guigoni C, Bezard E. Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesia. Parkinsonism & Related Disorders. 15: S64-7. PMID 20083011 DOI: 10.1016/S1353-8020(09)70783-7  0.384
2009 Dehorter N, Guigoni C, Lopez C, Hirsch J, Eusebio A, Ben-Ari Y, Hammond C. Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7776-87. PMID 19535589 DOI: 10.1523/Jneurosci.1527-09.2009  0.365
2009 Berton O, Guigoni C, Li Q, Bioulac BH, Aubert I, Gross CE, Dileone RJ, Nestler EJ, Bezard E. Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biological Psychiatry. 66: 554-61. PMID 19481198 DOI: 10.1016/J.Biopsych.2009.04.005  0.403
2008 Scholz B, Svensson M, Alm H, Sköld K, Fälth M, Kultima K, Guigoni C, Doudnikoff E, Li Q, Crossman AR, Bezard E, Andrén PE. Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. Plos One. 3: e1589. PMID 18270577 DOI: 10.1371/Journal.Pone.0001589  0.376
2007 Meissner W, Guigoni C, Cirilli L, Garret M, Bioulac BH, Gross CE, Bezard E, Benazzouz A. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease. The European Journal of Neuroscience. 25: 1492-500. PMID 17425575 DOI: 10.1111/J.1460-9568.2007.05406.X  0.343
2007 Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiology of Disease. 26: 452-63. PMID 17350277 DOI: 10.1016/J.Nbd.2007.02.001  0.425
2007 Scheller D, Chan P, Li Q, Wu T, Zhang R, Guan L, Ravenscroft P, Guigoni C, Crossman AR, Hill M, Bezard E. Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease. Experimental Neurology. 203: 415-22. PMID 17045989 DOI: 10.1016/J.Expneurol.2006.08.026  0.37
2007 Aubert I, Guigoni C, Li Q, Dovero S, Bioulac BH, Gross CE, Crossman AR, Bloch B, Bezard E. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biological Psychiatry. 61: 836-44. PMID 16950226 DOI: 10.1016/J.Biopsych.2006.06.038  0.302
2007 Bezard E, Berton O, Guigoni C, Dovero S, Kumar A, McClung C, DiLeone R, Nestler E. 2.501 Role of DeltaFosB in the development of L-DOPA-induced dyskinesia in a non-human primate model of Parkinson's disease Parkinsonism & Related Disorders. 13: S142. DOI: 10.1016/S1353-8020(08)70775-2  0.331
2006 Nadjar A, Brotchie JM, Guigoni C, Li Q, Zhou SB, Wang GJ, Ravenscroft P, Georges F, Crossman AR, Bezard E. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8653-61. PMID 16928853 DOI: 10.1523/Jneurosci.2582-06.2006  0.441
2005 Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. The European Journal of Neuroscience. 22: 283-7. PMID 16029219 DOI: 10.1111/J.1460-9568.2005.04196.X  0.327
2005 Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, HÃ¥kansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, et al. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders. 11: S25-9. PMID 15885624 DOI: 10.1016/J.Parkreldis.2004.11.005  0.388
2005 Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E. Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2102-7. PMID 15728850 DOI: 10.1523/Jneurosci.5059-04.2005  0.351
2005 Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/Ana.20296  0.392
2002 Guigoni C, Coulon P. Rabies virus is not cytolytic for rat spinal motoneurons in vitro. Journal of Neurovirology. 8: 306-17. PMID 12161815 DOI: 10.1080/13550280290100761  0.413
Show low-probability matches.